Literature DB >> 20360423

Telemetry in a motion-sickness model implicates the abdominal vagus in motion-induced gastric dysrhythmia.

Nathalie Percie du Sert1, Kit M Chu, Man K Wai, John A Rudd, Paul L R Andrews.   

Abstract

In humans, motion sickness is associated with disruption of normal gastric myoelectric activity, and it has been proposed that this results from an imbalance of autonomic nervous system activity. We used the established Suncus murinus (house musk shrew) model of motion-induced emesis to investigate the effect of horizontal motion on gastric myoelectric activity (recorded using telemetry) and the involvement of the abdominal vagi. Surgical vagotomy increased baseline dysrhythmia and reduced the dominant power of the gastric myoelectric signals. In response to motion, normal gastric myoelectric activity was reduced in sham-operated animals but not in vagotomized animals. Vagotomy, however, failed to affect motion-induced emesis. In conclusion, motion had a differential effect in sham-operated and vagotomized animals, which is consistent with the hypothesis that motion-induced dysrhythmia arises from an autonomic nervous system imbalance.

Entities:  

Mesh:

Year:  2010        PMID: 20360423     DOI: 10.1113/expphysiol.2009.052001

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  19 in total

Review 1.  Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling.

Authors:  Charles C Horn
Journal:  Exp Brain Res       Date:  2014-05-28       Impact factor: 1.972

2.  Novel dynamic measures of emetic behavior in musk shrews.

Authors:  Charles C Horn; Hong Wang; Laureline Estival; Kelly Meyers; Magnus S Magnusson
Journal:  Auton Neurosci       Date:  2013-08-13       Impact factor: 3.145

3.  Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.

Authors:  Dong Huang; Kelly Meyers; Séverine Henry; Fernando De la Torre; Charles C Horn
Journal:  J Neurosci Methods       Date:  2011-03-15       Impact factor: 2.390

4.  Delineation of vagal emetic pathways: intragastric copper sulfate-induced emesis and viral tract tracing in musk shrews.

Authors:  Charles C Horn; Kelly Meyers; Audrey Lim; Matthew Dye; Diana Pak; Linda Rinaman; Bill J Yates
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

Review 5.  What is nausea? A historical analysis of changing views.

Authors:  Carey D Balaban; Bill J Yates
Journal:  Auton Neurosci       Date:  2016-07-16       Impact factor: 3.145

6.  Musk shrews selectively bred for motion sickness display increased anesthesia-induced vomiting.

Authors:  Charles C Horn; Kelly Meyers; Nicholas Oberlies
Journal:  Physiol Behav       Date:  2013-11-14

Review 7.  Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.

Authors:  Charles C Horn; William J Wallisch; Gregg E Homanics; John P Williams
Journal:  Eur J Pharmacol       Date:  2013-10-26       Impact factor: 4.432

8.  Impact of electrical stimulation of the stomach on gastric distension-induced emesis in the musk shrew.

Authors:  C C Horn; L Zirpel; M G Sciullo; D M Rosenberg
Journal:  Neurogastroenterol Motil       Date:  2016-04-12       Impact factor: 3.598

9.  The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).

Authors:  Longlong Tu; Zengbing Lu; Man P Ngan; Francis F Y Lam; Claudio Giuliano; Emanuela Lovati; Claudio Pietra; John A Rudd
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

10.  Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans.

Authors:  Adam D Farmer; Vin F Ban; Steven J Coen; Gareth J Sanger; Gareth J Barker; Michael A Gresty; Vincent P Giampietro; Steven C Williams; Dominic L Webb; Per M Hellström; Paul L R Andrews; Qasim Aziz
Journal:  J Physiol       Date:  2015-01-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.